Market revenue in 2023 | USD 21.6 million |
Market revenue in 2030 | USD 29.6 million |
Growth rate | 4.6% (CAGR from 2023 to 2030) |
Largest segment | Cardiopulmonary perfusion system |
Fastest growing segment | Cardiopulmonary Perfusion System |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Cardiopulmonary Perfusion System, Cell Perfusion System, Ex-Vivo Organ Perfusion System |
Key market players worldwide | Getinge AB ADR, Medtronic PLC, LivaNova PLC, Terumo Corp, Nipro Corp, Fresenius Medical Care AG, Repligen Corp, Spectrum Brands Holdings Inc, Merck KGaA, Xvivo Perfusion AB |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to perfusion systems market will help companies and investors design strategic landscapes.
Cardiopulmonary perfusion system was the largest segment with a revenue share of 46.3% in 2023. Horizon Databook has segmented the Brazil perfusion systems market based on cardiopulmonary perfusion system, cell perfusion system, ex-vivo organ perfusion system covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of country-level data and insights on the Brazil perfusion systems market , including forecasts for subscribers. This country databook contains high-level insights into Brazil perfusion systems market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account